| 1.2 |
5.9 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 1.0 |
3.1 |
GO:0071544 |
diphosphoinositol polyphosphate metabolic process(GO:0071543) diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 1.0 |
3.0 |
GO:2001139 |
negative regulation of postsynaptic membrane organization(GO:1901627) negative regulation of dendritic spine maintenance(GO:1902951) negative regulation of phospholipid efflux(GO:1902999) regulation of lipid transport across blood brain barrier(GO:1903000) negative regulation of lipid transport across blood brain barrier(GO:1903001) positive regulation of lipid transport across blood brain barrier(GO:1903002) negative regulation of phospholipid transport(GO:2001139) |
| 1.0 |
3.0 |
GO:0072070 |
loop of Henle development(GO:0072070) metanephric loop of Henle development(GO:0072236) |
| 0.9 |
3.8 |
GO:0071051 |
polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.9 |
2.8 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.9 |
4.3 |
GO:1902309 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.8 |
2.4 |
GO:0051342 |
regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.8 |
4.8 |
GO:1901837 |
negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.8 |
2.3 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.7 |
2.1 |
GO:0070625 |
zymogen granule exocytosis(GO:0070625) |
| 0.7 |
2.8 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.7 |
15.3 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.7 |
0.7 |
GO:1901252 |
regulation of intracellular transport of viral material(GO:1901252) |
| 0.7 |
2.0 |
GO:1904569 |
regulation of selenocysteine incorporation(GO:1904569) |
| 0.7 |
2.0 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.7 |
2.0 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.6 |
2.5 |
GO:0046013 |
regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.6 |
1.9 |
GO:0032817 |
regulation of natural killer cell proliferation(GO:0032817) positive regulation of natural killer cell proliferation(GO:0032819) |
| 0.6 |
1.8 |
GO:1903795 |
regulation of inorganic anion transmembrane transport(GO:1903795) |
| 0.6 |
1.2 |
GO:0006407 |
rRNA export from nucleus(GO:0006407) |
| 0.6 |
3.0 |
GO:0000430 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.6 |
2.3 |
GO:0031509 |
telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.6 |
1.1 |
GO:0036166 |
phenotypic switching(GO:0036166) |
| 0.6 |
1.1 |
GO:0016074 |
snoRNA metabolic process(GO:0016074) snoRNA processing(GO:0043144) |
| 0.6 |
1.7 |
GO:0002586 |
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.5 |
3.2 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.5 |
2.1 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.5 |
0.5 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.5 |
1.6 |
GO:2000562 |
negative regulation of interferon-gamma secretion(GO:1902714) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.5 |
2.1 |
GO:2000974 |
negative regulation of pro-B cell differentiation(GO:2000974) |
| 0.5 |
1.5 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.5 |
1.5 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.5 |
4.7 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.5 |
2.3 |
GO:2001270 |
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) |
| 0.5 |
2.8 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.5 |
2.3 |
GO:0045918 |
negative regulation of cytolysis(GO:0045918) |
| 0.4 |
0.9 |
GO:0072053 |
renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
| 0.4 |
1.3 |
GO:0072223 |
metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
| 0.4 |
0.4 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 0.4 |
2.1 |
GO:0072488 |
ammonium transmembrane transport(GO:0072488) |
| 0.4 |
0.8 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.4 |
1.2 |
GO:0061043 |
regulation of vascular wound healing(GO:0061043) |
| 0.4 |
2.1 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.4 |
1.2 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.4 |
0.8 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.4 |
0.4 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 0.4 |
5.6 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.4 |
1.6 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.4 |
1.9 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.4 |
1.9 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.4 |
10.2 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.4 |
1.1 |
GO:0019676 |
ammonia assimilation cycle(GO:0019676) |
| 0.4 |
1.9 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 0.4 |
2.2 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
| 0.4 |
0.4 |
GO:0043096 |
purine nucleobase salvage(GO:0043096) |
| 0.4 |
1.5 |
GO:0046950 |
cellular ketone body metabolic process(GO:0046950) |
| 0.4 |
0.7 |
GO:0032847 |
regulation of cellular pH reduction(GO:0032847) |
| 0.4 |
2.2 |
GO:0021555 |
midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.4 |
1.1 |
GO:1901228 |
positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 0.4 |
1.1 |
GO:0009223 |
pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.4 |
3.2 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.4 |
0.4 |
GO:1900110 |
negative regulation of histone H3-K9 dimethylation(GO:1900110) |
| 0.4 |
5.7 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.4 |
5.3 |
GO:0000338 |
protein deneddylation(GO:0000338) |
| 0.4 |
0.4 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.3 |
2.4 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.3 |
0.3 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.3 |
0.7 |
GO:0046101 |
hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.3 |
1.0 |
GO:0019401 |
alditol biosynthetic process(GO:0019401) |
| 0.3 |
2.0 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.3 |
0.3 |
GO:0045608 |
inhibition of neuroepithelial cell differentiation(GO:0002085) negative regulation of auditory receptor cell differentiation(GO:0045608) |
| 0.3 |
1.0 |
GO:1902071 |
regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
| 0.3 |
2.7 |
GO:0097034 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.3 |
1.0 |
GO:0090285 |
negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.3 |
1.3 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.3 |
2.0 |
GO:0001302 |
replicative cell aging(GO:0001302) |
| 0.3 |
1.0 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.3 |
1.0 |
GO:0019043 |
establishment of viral latency(GO:0019043) |
| 0.3 |
1.0 |
GO:0046671 |
negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.3 |
2.6 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.3 |
1.3 |
GO:0000957 |
mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.3 |
18.7 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.3 |
1.0 |
GO:1905065 |
cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) regulation of vascular smooth muscle cell differentiation(GO:1905063) positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
| 0.3 |
2.2 |
GO:1902416 |
positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
| 0.3 |
1.0 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 0.3 |
0.6 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.3 |
1.3 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.3 |
0.3 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.3 |
1.0 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.3 |
3.1 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.3 |
0.6 |
GO:0061030 |
epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.3 |
0.9 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.3 |
1.5 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.3 |
0.3 |
GO:0031284 |
positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.3 |
0.3 |
GO:1902415 |
regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
| 0.3 |
2.4 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.3 |
1.2 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.3 |
0.9 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.3 |
0.9 |
GO:1903774 |
positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.3 |
1.2 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.3 |
5.3 |
GO:0032981 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.3 |
0.9 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.3 |
0.3 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.3 |
0.9 |
GO:0070476 |
rRNA (guanine-N7)-methylation(GO:0070476) |
| 0.3 |
1.2 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
| 0.3 |
1.1 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.3 |
3.4 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.3 |
2.0 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.3 |
0.9 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.3 |
0.8 |
GO:2000468 |
regulation of peroxidase activity(GO:2000468) |
| 0.3 |
1.1 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.3 |
1.1 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.3 |
0.8 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.3 |
1.4 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.3 |
1.7 |
GO:0032796 |
uropod organization(GO:0032796) |
| 0.3 |
3.6 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.3 |
4.1 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.3 |
1.1 |
GO:0061724 |
lipophagy(GO:0061724) |
| 0.3 |
0.3 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.3 |
0.8 |
GO:0035880 |
embryonic nail plate morphogenesis(GO:0035880) |
| 0.3 |
1.1 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
| 0.3 |
2.2 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.3 |
1.4 |
GO:0046864 |
retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) alveolar primary septum development(GO:0061143) |
| 0.3 |
0.8 |
GO:0021893 |
cerebral cortex GABAergic interneuron fate commitment(GO:0021893) |
| 0.3 |
4.0 |
GO:0032785 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) |
| 0.3 |
0.8 |
GO:1900041 |
negative regulation of interleukin-2 secretion(GO:1900041) |
| 0.3 |
0.5 |
GO:0000479 |
endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
| 0.3 |
1.1 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.3 |
0.5 |
GO:0070417 |
cellular response to cold(GO:0070417) |
| 0.3 |
2.6 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.3 |
2.1 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.3 |
0.8 |
GO:2000501 |
natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
| 0.3 |
1.8 |
GO:0033689 |
negative regulation of osteoblast proliferation(GO:0033689) |
| 0.3 |
2.1 |
GO:0034983 |
peptidyl-lysine deacetylation(GO:0034983) |
| 0.3 |
2.3 |
GO:0006183 |
GTP biosynthetic process(GO:0006183) |
| 0.3 |
0.8 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.3 |
1.0 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.3 |
0.3 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.3 |
0.8 |
GO:0045409 |
negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
| 0.2 |
0.2 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.2 |
0.7 |
GO:0006538 |
glutamate catabolic process(GO:0006538) |
| 0.2 |
2.5 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.2 |
1.7 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.2 |
0.7 |
GO:0046104 |
thymidine metabolic process(GO:0046104) |
| 0.2 |
1.9 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.2 |
5.8 |
GO:0001893 |
maternal placenta development(GO:0001893) |
| 0.2 |
0.2 |
GO:0008214 |
protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
| 0.2 |
0.2 |
GO:0045900 |
negative regulation of translational elongation(GO:0045900) |
| 0.2 |
1.0 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.2 |
1.7 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.2 |
0.5 |
GO:1900158 |
negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
| 0.2 |
3.6 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.2 |
1.0 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.2 |
0.5 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.2 |
0.7 |
GO:0071898 |
regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 0.2 |
0.5 |
GO:1903772 |
regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.2 |
0.7 |
GO:0009182 |
purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
| 0.2 |
13.8 |
GO:1902600 |
hydrogen ion transmembrane transport(GO:1902600) |
| 0.2 |
0.7 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.2 |
0.9 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.2 |
1.2 |
GO:0035247 |
peptidyl-arginine omega-N-methylation(GO:0035247) |
| 0.2 |
1.4 |
GO:0033108 |
mitochondrial respiratory chain complex assembly(GO:0033108) |
| 0.2 |
0.5 |
GO:2000157 |
regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.2 |
3.2 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.2 |
0.7 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.2 |
0.2 |
GO:0045763 |
negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 0.2 |
1.1 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.2 |
0.9 |
GO:0034145 |
positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 0.2 |
0.2 |
GO:0090035 |
regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.2 |
1.1 |
GO:2001268 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.2 |
0.5 |
GO:0090187 |
positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.2 |
0.7 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.2 |
4.1 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.2 |
0.9 |
GO:1902570 |
protein localization to nucleolus(GO:1902570) |
| 0.2 |
0.7 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.2 |
0.7 |
GO:0031038 |
myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
| 0.2 |
0.7 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.2 |
0.7 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.2 |
0.4 |
GO:0002309 |
T cell proliferation involved in immune response(GO:0002309) |
| 0.2 |
0.2 |
GO:0006532 |
aspartate biosynthetic process(GO:0006532) |
| 0.2 |
0.7 |
GO:0002014 |
vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
| 0.2 |
0.7 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.2 |
0.9 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.2 |
0.6 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.2 |
1.5 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
| 0.2 |
0.8 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.2 |
0.8 |
GO:0021678 |
third ventricle development(GO:0021678) |
| 0.2 |
0.6 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.2 |
1.0 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.2 |
0.2 |
GO:0002035 |
brain renin-angiotensin system(GO:0002035) |
| 0.2 |
0.8 |
GO:0099624 |
regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
| 0.2 |
0.8 |
GO:0051582 |
positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.2 |
3.5 |
GO:1901663 |
quinone biosynthetic process(GO:1901663) |
| 0.2 |
0.8 |
GO:1904008 |
cellular response to salt(GO:1902075) response to monosodium glutamate(GO:1904008) cellular response to monosodium glutamate(GO:1904009) |
| 0.2 |
0.2 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.2 |
1.2 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.2 |
0.8 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.2 |
0.6 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.2 |
1.4 |
GO:1901977 |
negative regulation of cell cycle checkpoint(GO:1901977) |
| 0.2 |
1.4 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.2 |
0.8 |
GO:0042534 |
tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.2 |
0.8 |
GO:0070141 |
response to UV-A(GO:0070141) |
| 0.2 |
0.8 |
GO:1903026 |
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.2 |
0.2 |
GO:0000821 |
regulation of arginine metabolic process(GO:0000821) |
| 0.2 |
1.4 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.2 |
0.4 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.2 |
0.6 |
GO:0019478 |
D-amino acid catabolic process(GO:0019478) |
| 0.2 |
1.1 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.2 |
1.1 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.2 |
1.1 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.2 |
0.9 |
GO:2000630 |
positive regulation of miRNA metabolic process(GO:2000630) |
| 0.2 |
0.8 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.2 |
0.7 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.2 |
1.9 |
GO:1904153 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.2 |
1.1 |
GO:1904417 |
regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
| 0.2 |
1.3 |
GO:0006450 |
regulation of translational fidelity(GO:0006450) |
| 0.2 |
0.7 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.2 |
1.1 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.2 |
0.4 |
GO:0035990 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.2 |
0.5 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.2 |
0.5 |
GO:0001788 |
antibody-dependent cellular cytotoxicity(GO:0001788) |
| 0.2 |
3.1 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.2 |
0.2 |
GO:1901386 |
negative regulation of voltage-gated calcium channel activity(GO:1901386) |
| 0.2 |
0.5 |
GO:0032513 |
negative regulation of protein phosphatase type 2B activity(GO:0032513) |
| 0.2 |
0.7 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.2 |
0.2 |
GO:0034287 |
detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.2 |
3.2 |
GO:0071260 |
cellular response to mechanical stimulus(GO:0071260) |
| 0.2 |
0.7 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.2 |
0.9 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.2 |
1.6 |
GO:0032594 |
protein transport within lipid bilayer(GO:0032594) |
| 0.2 |
0.5 |
GO:0070543 |
response to linoleic acid(GO:0070543) |
| 0.2 |
0.4 |
GO:1900864 |
mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.2 |
0.4 |
GO:1902262 |
apoptotic process involved in patterning of blood vessels(GO:1902262) |
| 0.2 |
1.2 |
GO:0010748 |
negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
| 0.2 |
0.5 |
GO:0034475 |
U4 snRNA 3'-end processing(GO:0034475) |
| 0.2 |
8.2 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.2 |
0.2 |
GO:0043585 |
nose morphogenesis(GO:0043585) |
| 0.2 |
0.9 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.2 |
1.2 |
GO:0015868 |
purine ribonucleotide transport(GO:0015868) |
| 0.2 |
0.5 |
GO:0072180 |
mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) mesonephric duct development(GO:0072177) mesonephric duct morphogenesis(GO:0072180) |
| 0.2 |
0.2 |
GO:0060489 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 0.2 |
0.5 |
GO:0002447 |
eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
| 0.2 |
0.2 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.2 |
0.8 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.2 |
1.0 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.2 |
0.3 |
GO:0033484 |
nitric oxide homeostasis(GO:0033484) |
| 0.2 |
0.5 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.2 |
0.3 |
GO:2000040 |
regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
| 0.2 |
0.3 |
GO:0010958 |
regulation of amino acid import(GO:0010958) regulation of L-arginine import(GO:0010963) |
| 0.2 |
0.7 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 0.2 |
0.7 |
GO:0033499 |
galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
| 0.2 |
0.7 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.2 |
0.7 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.2 |
0.7 |
GO:0071025 |
RNA surveillance(GO:0071025) |
| 0.2 |
0.3 |
GO:0051029 |
rRNA transport(GO:0051029) |
| 0.2 |
0.3 |
GO:0046502 |
uroporphyrinogen III metabolic process(GO:0046502) |
| 0.2 |
1.8 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.2 |
0.2 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.2 |
0.6 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.2 |
0.6 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.2 |
0.6 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.2 |
0.5 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.2 |
1.4 |
GO:0015816 |
glycine transport(GO:0015816) |
| 0.2 |
0.6 |
GO:0070561 |
vitamin D receptor signaling pathway(GO:0070561) |
| 0.2 |
1.1 |
GO:0043206 |
extracellular fibril organization(GO:0043206) |
| 0.2 |
1.7 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.2 |
1.1 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.2 |
0.6 |
GO:0006924 |
activation-induced cell death of T cells(GO:0006924) |
| 0.2 |
0.5 |
GO:1902166 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
| 0.2 |
1.1 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.2 |
1.1 |
GO:1903333 |
negative regulation of protein folding(GO:1903333) |
| 0.2 |
0.3 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.2 |
1.2 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.2 |
0.6 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.2 |
0.6 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.2 |
0.2 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.2 |
0.6 |
GO:0000447 |
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.1 |
1.2 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.1 |
0.4 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.1 |
0.3 |
GO:0016259 |
selenocysteine metabolic process(GO:0016259) |
| 0.1 |
0.4 |
GO:1902774 |
late endosome to lysosome transport(GO:1902774) |
| 0.1 |
1.6 |
GO:0009143 |
nucleoside triphosphate catabolic process(GO:0009143) |
| 0.1 |
1.3 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.1 |
0.4 |
GO:0017055 |
negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 0.1 |
0.6 |
GO:0032788 |
saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
| 0.1 |
0.7 |
GO:1903204 |
negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.1 |
1.8 |
GO:0042182 |
ketone catabolic process(GO:0042182) |
| 0.1 |
0.9 |
GO:0015817 |
histidine transport(GO:0015817) |
| 0.1 |
0.4 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.1 |
0.6 |
GO:0010288 |
response to lead ion(GO:0010288) |
| 0.1 |
0.4 |
GO:0008655 |
pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.1 |
0.9 |
GO:0031666 |
positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.1 |
0.1 |
GO:0008611 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
| 0.1 |
0.6 |
GO:0070837 |
dehydroascorbic acid transport(GO:0070837) |
| 0.1 |
1.0 |
GO:0071428 |
rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
| 0.1 |
0.9 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.1 |
0.7 |
GO:0051182 |
coenzyme transport(GO:0051182) |
| 0.1 |
1.3 |
GO:0061099 |
negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.1 |
0.9 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.1 |
0.3 |
GO:0046668 |
regulation of retinal cell programmed cell death(GO:0046668) |
| 0.1 |
1.6 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.1 |
0.4 |
GO:0042196 |
dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 0.1 |
0.6 |
GO:0001767 |
establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
| 0.1 |
0.3 |
GO:0097503 |
sialylation(GO:0097503) |
| 0.1 |
0.4 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.1 |
0.4 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) |
| 0.1 |
0.4 |
GO:0071335 |
hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
| 0.1 |
0.4 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.1 |
0.4 |
GO:0009189 |
deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
| 0.1 |
0.6 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.1 |
0.6 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.1 |
1.2 |
GO:0015697 |
quaternary ammonium group transport(GO:0015697) |
| 0.1 |
1.0 |
GO:0015840 |
urea transport(GO:0015840) urea transmembrane transport(GO:0071918) |
| 0.1 |
1.0 |
GO:1901162 |
serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
| 0.1 |
1.1 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.1 |
0.8 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.1 |
0.9 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.1 |
0.8 |
GO:0006833 |
water transport(GO:0006833) |
| 0.1 |
0.9 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
| 0.1 |
0.3 |
GO:2000852 |
regulation of corticosterone secretion(GO:2000852) |
| 0.1 |
0.3 |
GO:1903596 |
regulation of gap junction assembly(GO:1903596) |
| 0.1 |
4.7 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.1 |
1.3 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.1 |
0.5 |
GO:0019755 |
one-carbon compound transport(GO:0019755) |
| 0.1 |
1.8 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.1 |
0.1 |
GO:0090274 |
positive regulation of somatostatin secretion(GO:0090274) |
| 0.1 |
0.3 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) |
| 0.1 |
0.1 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.1 |
0.8 |
GO:1902514 |
regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
| 0.1 |
0.4 |
GO:0009068 |
aspartate family amino acid catabolic process(GO:0009068) |
| 0.1 |
0.5 |
GO:0017183 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.1 |
0.4 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 |
0.8 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.1 |
2.1 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.1 |
0.3 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 0.1 |
1.2 |
GO:0033683 |
nucleotide-excision repair, DNA incision(GO:0033683) |
| 0.1 |
0.8 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 0.1 |
0.3 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 0.1 |
0.4 |
GO:1902965 |
regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 0.1 |
0.1 |
GO:0003219 |
cardiac right ventricle formation(GO:0003219) |
| 0.1 |
0.4 |
GO:0034447 |
very-low-density lipoprotein particle clearance(GO:0034447) |
| 0.1 |
0.1 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.1 |
0.5 |
GO:0007320 |
insemination(GO:0007320) |
| 0.1 |
0.9 |
GO:0070447 |
positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
| 0.1 |
0.6 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.1 |
2.3 |
GO:0010667 |
negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.1 |
0.4 |
GO:0046032 |
ADP catabolic process(GO:0046032) IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 0.1 |
0.6 |
GO:0042590 |
antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.1 |
1.7 |
GO:0044243 |
collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
| 0.1 |
0.5 |
GO:2000109 |
macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
| 0.1 |
0.5 |
GO:1904715 |
negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.1 |
0.9 |
GO:0071340 |
skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.1 |
0.6 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.1 |
0.6 |
GO:1905098 |
negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.1 |
0.7 |
GO:1902988 |
neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
| 0.1 |
0.4 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.1 |
0.7 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.1 |
0.2 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.1 |
3.5 |
GO:0009206 |
purine ribonucleoside triphosphate biosynthetic process(GO:0009206) |
| 0.1 |
0.6 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.1 |
2.1 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.1 |
0.2 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.1 |
0.4 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.1 |
0.9 |
GO:0035092 |
sperm chromatin condensation(GO:0035092) |
| 0.1 |
3.1 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.1 |
0.5 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.1 |
0.9 |
GO:0043486 |
histone exchange(GO:0043486) |
| 0.1 |
0.9 |
GO:0071816 |
protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.1 |
0.8 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.1 |
0.2 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
| 0.1 |
1.4 |
GO:0060261 |
positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.1 |
0.2 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.1 |
1.6 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.1 |
0.5 |
GO:0009142 |
nucleoside triphosphate biosynthetic process(GO:0009142) |
| 0.1 |
0.6 |
GO:0033033 |
negative regulation of myeloid cell apoptotic process(GO:0033033) |
| 0.1 |
0.8 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.1 |
0.7 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.1 |
0.8 |
GO:0032825 |
positive regulation of natural killer cell differentiation(GO:0032825) |
| 0.1 |
0.5 |
GO:0015744 |
succinate transport(GO:0015744) |
| 0.1 |
0.2 |
GO:1900369 |
negative regulation of RNA interference(GO:1900369) |
| 0.1 |
0.1 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.1 |
0.1 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.1 |
0.5 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.1 |
1.2 |
GO:1903427 |
negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
| 0.1 |
0.9 |
GO:0042523 |
positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
| 0.1 |
0.1 |
GO:0009438 |
methylglyoxal metabolic process(GO:0009438) |
| 0.1 |
0.1 |
GO:0046321 |
positive regulation of fatty acid oxidation(GO:0046321) |
| 0.1 |
0.3 |
GO:1904177 |
regulation of adipose tissue development(GO:1904177) |
| 0.1 |
0.4 |
GO:0003150 |
muscular septum morphogenesis(GO:0003150) |
| 0.1 |
0.3 |
GO:0070384 |
Harderian gland development(GO:0070384) |
| 0.1 |
0.2 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.1 |
0.3 |
GO:0009263 |
deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.1 |
1.5 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
| 0.1 |
1.8 |
GO:0007530 |
sex determination(GO:0007530) |
| 0.1 |
0.2 |
GO:0060753 |
regulation of mast cell chemotaxis(GO:0060753) |
| 0.1 |
0.5 |
GO:1901727 |
positive regulation of histone deacetylase activity(GO:1901727) |
| 0.1 |
0.7 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 |
0.9 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.1 |
1.4 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.1 |
0.4 |
GO:0002438 |
acute inflammatory response to antigenic stimulus(GO:0002438) |
| 0.1 |
0.4 |
GO:0021586 |
pons maturation(GO:0021586) |
| 0.1 |
0.8 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.1 |
2.3 |
GO:0060914 |
heart formation(GO:0060914) |
| 0.1 |
0.3 |
GO:0030262 |
cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
| 0.1 |
0.1 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.1 |
0.1 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.1 |
0.8 |
GO:0042659 |
regulation of cell fate specification(GO:0042659) |
| 0.1 |
0.4 |
GO:0030049 |
muscle filament sliding(GO:0030049) |
| 0.1 |
1.7 |
GO:0009083 |
branched-chain amino acid catabolic process(GO:0009083) |
| 0.1 |
0.4 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.1 |
0.3 |
GO:0060785 |
regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
| 0.1 |
0.3 |
GO:1900147 |
Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.1 |
0.1 |
GO:2001015 |
negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 0.1 |
0.4 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.1 |
0.3 |
GO:0010749 |
regulation of nitric oxide mediated signal transduction(GO:0010749) |
| 0.1 |
0.2 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.1 |
0.2 |
GO:1902219 |
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.1 |
0.7 |
GO:0042541 |
hemoglobin biosynthetic process(GO:0042541) |
| 0.1 |
0.4 |
GO:1902430 |
negative regulation of beta-amyloid formation(GO:1902430) |
| 0.1 |
0.3 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.1 |
1.2 |
GO:0031295 |
lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
| 0.1 |
0.2 |
GO:0021508 |
floor plate formation(GO:0021508) floor plate morphogenesis(GO:0033505) |
| 0.1 |
0.4 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.1 |
0.7 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.1 |
0.3 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.1 |
0.2 |
GO:2000343 |
positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
| 0.1 |
0.7 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.1 |
0.3 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.1 |
0.4 |
GO:0070827 |
chromatin maintenance(GO:0070827) heterochromatin maintenance(GO:0070829) |
| 0.1 |
2.5 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.1 |
0.3 |
GO:2000418 |
positive regulation of eosinophil migration(GO:2000418) |
| 0.1 |
0.2 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 |
0.7 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.1 |
1.2 |
GO:0045624 |
positive regulation of T-helper cell differentiation(GO:0045624) |
| 0.1 |
0.5 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.1 |
3.1 |
GO:1903146 |
regulation of mitophagy(GO:1903146) |
| 0.1 |
0.5 |
GO:1904936 |
cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.1 |
0.3 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.1 |
4.4 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.1 |
0.6 |
GO:0045649 |
regulation of macrophage differentiation(GO:0045649) |
| 0.1 |
1.4 |
GO:1901028 |
regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901028) |
| 0.1 |
0.1 |
GO:0072554 |
dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) blood vessel lumenization(GO:0072554) |
| 0.1 |
1.8 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.1 |
0.6 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.1 |
0.6 |
GO:0039703 |
viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.1 |
1.1 |
GO:0001516 |
prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
| 0.1 |
0.6 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 |
1.7 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.1 |
0.4 |
GO:0010991 |
regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.1 |
0.5 |
GO:0010884 |
positive regulation of lipid storage(GO:0010884) |
| 0.1 |
0.3 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.1 |
0.8 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.1 |
0.4 |
GO:0042905 |
9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.1 |
0.4 |
GO:0070589 |
cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
| 0.1 |
1.5 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.1 |
2.8 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.1 |
0.1 |
GO:0031282 |
regulation of guanylate cyclase activity(GO:0031282) |
| 0.1 |
0.5 |
GO:0014029 |
neural crest formation(GO:0014029) |
| 0.1 |
1.1 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.1 |
0.6 |
GO:0021780 |
oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.1 |
0.4 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.1 |
0.1 |
GO:0021882 |
regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
| 0.1 |
0.3 |
GO:0033092 |
positive regulation of immature T cell proliferation(GO:0033091) positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 0.1 |
1.5 |
GO:0051602 |
response to electrical stimulus(GO:0051602) |
| 0.1 |
0.2 |
GO:0010626 |
negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.1 |
0.3 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.1 |
0.5 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.1 |
0.6 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
| 0.1 |
0.3 |
GO:0031990 |
mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.1 |
0.2 |
GO:0010896 |
regulation of triglyceride catabolic process(GO:0010896) |
| 0.1 |
0.8 |
GO:0030538 |
embryonic genitalia morphogenesis(GO:0030538) embryonic hindgut morphogenesis(GO:0048619) |
| 0.1 |
0.2 |
GO:0032066 |
nucleolus to nucleoplasm transport(GO:0032066) |
| 0.1 |
0.2 |
GO:1903867 |
chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
| 0.1 |
0.2 |
GO:1900039 |
positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.1 |
0.3 |
GO:0030656 |
regulation of vitamin metabolic process(GO:0030656) |
| 0.1 |
0.8 |
GO:0097084 |
vascular smooth muscle cell development(GO:0097084) |
| 0.1 |
3.8 |
GO:0009060 |
aerobic respiration(GO:0009060) |
| 0.1 |
0.3 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.1 |
0.3 |
GO:0007512 |
adult heart development(GO:0007512) |
| 0.1 |
1.2 |
GO:0033599 |
regulation of mammary gland epithelial cell proliferation(GO:0033599) |
| 0.1 |
0.1 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.1 |
0.6 |
GO:0051788 |
response to misfolded protein(GO:0051788) |
| 0.1 |
0.7 |
GO:0034122 |
negative regulation of toll-like receptor signaling pathway(GO:0034122) |
| 0.1 |
0.3 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.1 |
0.2 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.1 |
0.4 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.1 |
0.4 |
GO:0046600 |
negative regulation of centriole replication(GO:0046600) |
| 0.1 |
0.4 |
GO:0070092 |
glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 0.1 |
0.2 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.1 |
0.4 |
GO:0035902 |
response to immobilization stress(GO:0035902) |
| 0.1 |
0.3 |
GO:0001834 |
trophectodermal cell proliferation(GO:0001834) |
| 0.1 |
0.2 |
GO:0098915 |
membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
| 0.1 |
0.4 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.1 |
0.1 |
GO:1902172 |
keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
| 0.1 |
0.5 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.1 |
0.3 |
GO:0070305 |
response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 0.1 |
0.4 |
GO:0009133 |
nucleoside diphosphate biosynthetic process(GO:0009133) |
| 0.1 |
0.2 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.1 |
0.5 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.1 |
1.0 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.1 |
0.5 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.1 |
0.3 |
GO:2000195 |
negative regulation of female gonad development(GO:2000195) |
| 0.1 |
0.6 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.1 |
0.5 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.1 |
0.2 |
GO:0035356 |
cellular triglyceride homeostasis(GO:0035356) |
| 0.1 |
0.3 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.1 |
0.1 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.1 |
0.8 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.1 |
0.9 |
GO:2000398 |
regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.1 |
0.4 |
GO:0018002 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.1 |
0.3 |
GO:0051987 |
positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
| 0.1 |
0.8 |
GO:0036159 |
inner dynein arm assembly(GO:0036159) |
| 0.1 |
1.4 |
GO:0006656 |
phosphatidylcholine biosynthetic process(GO:0006656) |
| 0.1 |
0.5 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.1 |
0.8 |
GO:2000643 |
positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.1 |
0.3 |
GO:2000587 |
regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.1 |
3.1 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.1 |
0.5 |
GO:0032331 |
negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.1 |
0.4 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.1 |
0.3 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.1 |
0.1 |
GO:0010835 |
regulation of protein ADP-ribosylation(GO:0010835) |
| 0.1 |
0.2 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.1 |
0.6 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.1 |
0.3 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.1 |
0.2 |
GO:0070344 |
fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) |
| 0.1 |
0.4 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.1 |
0.7 |
GO:0032506 |
cytokinetic process(GO:0032506) |
| 0.1 |
0.4 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.1 |
1.2 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.1 |
9.3 |
GO:0042254 |
ribosome biogenesis(GO:0042254) |
| 0.1 |
0.8 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 0.1 |
0.3 |
GO:0046958 |
nonassociative learning(GO:0046958) |
| 0.1 |
0.8 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.1 |
0.1 |
GO:0018126 |
protein hydroxylation(GO:0018126) |
| 0.1 |
0.4 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.1 |
0.1 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) |
| 0.1 |
0.9 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.1 |
0.4 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.1 |
0.1 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.1 |
0.1 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 0.1 |
0.3 |
GO:0042346 |
positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 0.1 |
0.7 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.1 |
0.2 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.1 |
1.1 |
GO:0061154 |
endothelial tube morphogenesis(GO:0061154) |
| 0.1 |
0.5 |
GO:0006363 |
termination of RNA polymerase I transcription(GO:0006363) |
| 0.1 |
0.2 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.1 |
0.1 |
GO:0060160 |
negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.1 |
0.2 |
GO:0097274 |
urea homeostasis(GO:0097274) |
| 0.1 |
0.3 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.1 |
0.5 |
GO:1904587 |
glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
| 0.1 |
0.2 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.1 |
0.1 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.1 |
0.2 |
GO:0035582 |
sequestering of BMP in extracellular matrix(GO:0035582) |
| 0.1 |
0.7 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 |
0.4 |
GO:0090267 |
positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 0.1 |
0.5 |
GO:0070458 |
detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.1 |
2.0 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 |
1.2 |
GO:0033119 |
negative regulation of RNA splicing(GO:0033119) |
| 0.1 |
0.2 |
GO:0008050 |
courtship behavior(GO:0007619) female courtship behavior(GO:0008050) |
| 0.1 |
1.7 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.1 |
1.4 |
GO:0006220 |
pyrimidine nucleotide metabolic process(GO:0006220) |
| 0.1 |
0.1 |
GO:0019240 |
citrulline biosynthetic process(GO:0019240) |
| 0.1 |
0.3 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.1 |
0.1 |
GO:0072600 |
establishment of protein localization to Golgi(GO:0072600) |
| 0.1 |
0.2 |
GO:0001980 |
regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
| 0.1 |
1.3 |
GO:0032469 |
endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.1 |
0.3 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.1 |
0.1 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
| 0.1 |
0.5 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.1 |
0.3 |
GO:0032962 |
regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
| 0.1 |
0.9 |
GO:0031643 |
positive regulation of myelination(GO:0031643) |
| 0.1 |
0.1 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.1 |
0.3 |
GO:1900037 |
regulation of cellular response to hypoxia(GO:1900037) |
| 0.1 |
0.4 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.1 |
0.1 |
GO:0090494 |
catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 0.1 |
0.5 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.1 |
0.3 |
GO:0032201 |
telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.1 |
0.1 |
GO:0061009 |
common bile duct development(GO:0061009) |
| 0.1 |
0.3 |
GO:0030299 |
intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
| 0.1 |
0.1 |
GO:0000087 |
mitotic M phase(GO:0000087) mitotic cell cycle phase(GO:0098763) |
| 0.1 |
0.3 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.1 |
0.2 |
GO:1902969 |
mitotic DNA replication(GO:1902969) |
| 0.1 |
0.2 |
GO:0032430 |
positive regulation of phospholipase A2 activity(GO:0032430) |
| 0.1 |
0.4 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.1 |
0.3 |
GO:0036265 |
RNA (guanine-N7)-methylation(GO:0036265) |
| 0.1 |
0.2 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.1 |
0.6 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.1 |
0.4 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.1 |
0.6 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.1 |
0.1 |
GO:0071372 |
response to follicle-stimulating hormone(GO:0032354) cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.1 |
0.4 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 0.1 |
0.6 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.1 |
0.2 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.1 |
0.9 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.1 |
0.9 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
| 0.1 |
0.5 |
GO:0032793 |
positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.1 |
0.1 |
GO:2000489 |
hepatic stellate cell activation(GO:0035733) regulation of hepatic stellate cell activation(GO:2000489) |
| 0.1 |
0.2 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.1 |
1.5 |
GO:0060393 |
regulation of pathway-restricted SMAD protein phosphorylation(GO:0060393) |
| 0.1 |
0.2 |
GO:0060352 |
cell adhesion molecule production(GO:0060352) |
| 0.1 |
0.1 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.1 |
1.0 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.1 |
0.5 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.1 |
0.9 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 |
0.5 |
GO:0010972 |
negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
| 0.1 |
0.2 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.1 |
0.1 |
GO:0071072 |
negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.1 |
0.4 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.1 |
0.2 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.1 |
0.4 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.1 |
0.1 |
GO:0021593 |
rhombomere morphogenesis(GO:0021593) |
| 0.1 |
1.0 |
GO:0006401 |
RNA catabolic process(GO:0006401) |
| 0.1 |
0.8 |
GO:0014049 |
positive regulation of glutamate secretion(GO:0014049) |
| 0.1 |
0.4 |
GO:0060033 |
anatomical structure regression(GO:0060033) |
| 0.1 |
0.4 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.1 |
0.3 |
GO:0016560 |
protein import into peroxisome matrix, docking(GO:0016560) |
| 0.1 |
0.3 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.1 |
1.5 |
GO:0006368 |
transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.1 |
0.2 |
GO:0060217 |
positive regulation of chromatin assembly or disassembly(GO:0045799) hemangioblast cell differentiation(GO:0060217) |
| 0.1 |
0.1 |
GO:0006285 |
base-excision repair, AP site formation(GO:0006285) |
| 0.1 |
0.5 |
GO:0032096 |
negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.1 |
0.6 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.1 |
0.3 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.1 |
0.3 |
GO:0072429 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.1 |
0.3 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.1 |
0.1 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.1 |
0.1 |
GO:0035106 |
operant conditioning(GO:0035106) |
| 0.1 |
0.3 |
GO:0070171 |
negative regulation of tooth mineralization(GO:0070171) |
| 0.1 |
0.1 |
GO:0002430 |
complement receptor mediated signaling pathway(GO:0002430) |
| 0.1 |
0.3 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.1 |
0.2 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.1 |
0.4 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.1 |
0.2 |
GO:0048524 |
positive regulation of viral process(GO:0048524) |
| 0.1 |
0.3 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.1 |
0.1 |
GO:0001844 |
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
| 0.1 |
0.1 |
GO:0002513 |
tolerance induction to self antigen(GO:0002513) |
| 0.1 |
0.3 |
GO:0050912 |
detection of chemical stimulus involved in sensory perception(GO:0050907) detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
| 0.1 |
0.9 |
GO:0001706 |
endoderm formation(GO:0001706) |
| 0.1 |
0.1 |
GO:0001556 |
oocyte maturation(GO:0001556) |
| 0.1 |
0.2 |
GO:0033580 |
protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
| 0.1 |
0.3 |
GO:2000010 |
positive regulation of protein localization to cell surface(GO:2000010) |
| 0.1 |
0.3 |
GO:0030836 |
positive regulation of actin filament depolymerization(GO:0030836) |
| 0.1 |
0.2 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.1 |
0.2 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.1 |
1.8 |
GO:0030968 |
endoplasmic reticulum unfolded protein response(GO:0030968) |
| 0.1 |
0.3 |
GO:0001547 |
antral ovarian follicle growth(GO:0001547) |
| 0.1 |
0.2 |
GO:0048478 |
replication fork protection(GO:0048478) |
| 0.1 |
0.9 |
GO:0046040 |
IMP metabolic process(GO:0046040) |
| 0.1 |
0.3 |
GO:0051123 |
RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.1 |
0.2 |
GO:0038089 |
positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
| 0.1 |
0.2 |
GO:0071639 |
positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
| 0.1 |
0.3 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.1 |
0.1 |
GO:0019087 |
transformation of host cell by virus(GO:0019087) |
| 0.1 |
0.2 |
GO:0097178 |
ruffle assembly(GO:0097178) |
| 0.1 |
0.3 |
GO:0090043 |
tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
| 0.1 |
0.3 |
GO:0014816 |
skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.1 |
0.3 |
GO:0051149 |
positive regulation of muscle cell differentiation(GO:0051149) |
| 0.0 |
0.2 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.0 |
0.4 |
GO:0010719 |
negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.0 |
0.1 |
GO:0000393 |
spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.0 |
0.2 |
GO:0006048 |
UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.0 |
0.1 |
GO:1902306 |
negative regulation of sodium ion transmembrane transport(GO:1902306) |
| 0.0 |
0.2 |
GO:0043137 |
DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
| 0.0 |
0.1 |
GO:0021978 |
telencephalon regionalization(GO:0021978) |
| 0.0 |
0.3 |
GO:0016048 |
detection of temperature stimulus(GO:0016048) |
| 0.0 |
0.1 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.0 |
0.1 |
GO:0071493 |
cellular response to UV-B(GO:0071493) |
| 0.0 |
0.1 |
GO:1900060 |
negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.0 |
0.1 |
GO:0051004 |
regulation of lipoprotein lipase activity(GO:0051004) |
| 0.0 |
0.1 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.0 |
1.8 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 |
0.2 |
GO:0010759 |
positive regulation of macrophage chemotaxis(GO:0010759) |
| 0.0 |
0.2 |
GO:0046210 |
regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.0 |
0.4 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.0 |
2.6 |
GO:0006635 |
fatty acid beta-oxidation(GO:0006635) |
| 0.0 |
0.1 |
GO:0032693 |
negative regulation of interleukin-10 production(GO:0032693) |
| 0.0 |
0.5 |
GO:0045063 |
T-helper 1 cell differentiation(GO:0045063) |
| 0.0 |
0.6 |
GO:1902042 |
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
| 0.0 |
0.1 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.0 |
0.3 |
GO:0061436 |
establishment of skin barrier(GO:0061436) |
| 0.0 |
0.5 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.0 |
1.7 |
GO:0006749 |
glutathione metabolic process(GO:0006749) |
| 0.0 |
0.8 |
GO:2001240 |
negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
| 0.0 |
0.2 |
GO:1904294 |
positive regulation of ERAD pathway(GO:1904294) |
| 0.0 |
0.5 |
GO:0032967 |
positive regulation of collagen biosynthetic process(GO:0032967) |
| 0.0 |
0.0 |
GO:0009812 |
flavonoid metabolic process(GO:0009812) flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
| 0.0 |
0.6 |
GO:0006308 |
DNA catabolic process(GO:0006308) |
| 0.0 |
0.1 |
GO:1900220 |
negative regulation of alkaline phosphatase activity(GO:0010693) semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.0 |
0.6 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.0 |
0.5 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.0 |
0.2 |
GO:0070989 |
oxidative demethylation(GO:0070989) |
| 0.0 |
0.4 |
GO:0009303 |
rRNA transcription(GO:0009303) |
| 0.0 |
0.2 |
GO:0009642 |
response to light intensity(GO:0009642) |
| 0.0 |
0.3 |
GO:0060312 |
regulation of blood vessel remodeling(GO:0060312) |
| 0.0 |
0.2 |
GO:1900016 |
negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.0 |
0.6 |
GO:0006658 |
phosphatidylserine metabolic process(GO:0006658) |
| 0.0 |
0.3 |
GO:0050966 |
detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
| 0.0 |
1.1 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.0 |
0.9 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.0 |
0.0 |
GO:0002551 |
mast cell chemotaxis(GO:0002551) |
| 0.0 |
0.9 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.0 |
0.3 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.0 |
1.4 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.0 |
0.1 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) |
| 0.0 |
0.3 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.0 |
0.2 |
GO:0006103 |
2-oxoglutarate metabolic process(GO:0006103) |
| 0.0 |
0.5 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.0 |
0.6 |
GO:0061098 |
positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.0 |
0.1 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.0 |
0.0 |
GO:2000642 |
negative regulation of vacuolar transport(GO:1903336) negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.0 |
0.7 |
GO:0045070 |
positive regulation of viral genome replication(GO:0045070) |
| 0.0 |
0.1 |
GO:0021940 |
positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
| 0.0 |
0.2 |
GO:0042574 |
retinal metabolic process(GO:0042574) |
| 0.0 |
0.3 |
GO:0060561 |
apoptotic process involved in morphogenesis(GO:0060561) |
| 0.0 |
0.0 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.0 |
1.3 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
| 0.0 |
0.7 |
GO:0035458 |
cellular response to interferon-beta(GO:0035458) |
| 0.0 |
0.3 |
GO:0030866 |
cortical actin cytoskeleton organization(GO:0030866) |
| 0.0 |
0.1 |
GO:0048611 |
ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 0.0 |
0.5 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.0 |
0.1 |
GO:0071674 |
chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) corticospinal neuron axon guidance through spinal cord(GO:0021972) positive regulation of negative chemotaxis(GO:0050924) induction of negative chemotaxis(GO:0050929) mammary duct terminal end bud growth(GO:0060763) mononuclear cell migration(GO:0071674) negative regulation of mononuclear cell migration(GO:0071676) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
| 0.0 |
12.3 |
GO:0006412 |
translation(GO:0006412) |
| 0.0 |
0.1 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.0 |
0.5 |
GO:0022904 |
respiratory electron transport chain(GO:0022904) |
| 0.0 |
0.2 |
GO:0035188 |
blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.0 |
0.1 |
GO:0046689 |
response to mercury ion(GO:0046689) |
| 0.0 |
0.1 |
GO:0016925 |
protein sumoylation(GO:0016925) |
| 0.0 |
0.3 |
GO:0030224 |
monocyte differentiation(GO:0030224) |
| 0.0 |
0.1 |
GO:0002689 |
negative regulation of leukocyte chemotaxis(GO:0002689) |
| 0.0 |
0.2 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.0 |
0.5 |
GO:0030497 |
fatty acid elongation(GO:0030497) |
| 0.0 |
0.4 |
GO:0034067 |
protein localization to Golgi apparatus(GO:0034067) |
| 0.0 |
0.1 |
GO:0006353 |
DNA-templated transcription, termination(GO:0006353) |
| 0.0 |
0.3 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.0 |
0.1 |
GO:0045213 |
neurotransmitter receptor metabolic process(GO:0045213) |
| 0.0 |
0.1 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.0 |
0.1 |
GO:0051642 |
centrosome localization(GO:0051642) |
| 0.0 |
0.3 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.0 |
0.2 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.0 |
0.1 |
GO:0061325 |
deltoid tuberosity development(GO:0035993) cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
| 0.0 |
0.2 |
GO:0009448 |
gamma-aminobutyric acid metabolic process(GO:0009448) gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.0 |
0.4 |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.0 |
0.2 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.0 |
0.0 |
GO:0000731 |
DNA synthesis involved in DNA repair(GO:0000731) |
| 0.0 |
0.2 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.0 |
0.7 |
GO:0005978 |
glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.0 |
0.1 |
GO:0097680 |
double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.0 |
0.2 |
GO:0042517 |
positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
| 0.0 |
0.0 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.0 |
0.1 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 0.0 |
0.3 |
GO:0071800 |
podosome assembly(GO:0071800) |
| 0.0 |
0.5 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.0 |
0.6 |
GO:0001837 |
epithelial to mesenchymal transition(GO:0001837) |
| 0.0 |
0.2 |
GO:0071467 |
cellular response to pH(GO:0071467) |
| 0.0 |
0.1 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.0 |
0.1 |
GO:0030647 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.0 |
0.2 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.0 |
0.1 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.0 |
0.2 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.0 |
0.3 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.0 |
0.1 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.0 |
0.2 |
GO:0010470 |
regulation of gastrulation(GO:0010470) |
| 0.0 |
0.2 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.0 |
0.1 |
GO:0006787 |
porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
| 0.0 |
0.2 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.0 |
0.4 |
GO:0072337 |
modified amino acid transport(GO:0072337) |
| 0.0 |
0.4 |
GO:0010596 |
negative regulation of endothelial cell migration(GO:0010596) |
| 0.0 |
0.1 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 0.0 |
0.1 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.0 |
0.4 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.0 |
0.4 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.0 |
0.2 |
GO:0048011 |
neurotrophin TRK receptor signaling pathway(GO:0048011) |
| 0.0 |
0.1 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.0 |
0.1 |
GO:0015936 |
coenzyme A metabolic process(GO:0015936) |
| 0.0 |
0.1 |
GO:0051895 |
negative regulation of focal adhesion assembly(GO:0051895) negative regulation of adherens junction organization(GO:1903392) |
| 0.0 |
0.1 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.0 |
0.1 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.0 |
0.5 |
GO:0022617 |
extracellular matrix disassembly(GO:0022617) |
| 0.0 |
0.3 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.0 |
0.3 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.0 |
0.0 |
GO:0030201 |
heparan sulfate proteoglycan metabolic process(GO:0030201) |
| 0.0 |
0.2 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.0 |
0.0 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.0 |
0.3 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.0 |
0.1 |
GO:0006655 |
phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin biosynthetic process(GO:0032049) |
| 0.0 |
0.0 |
GO:0002566 |
somatic diversification of immune receptors via somatic mutation(GO:0002566) |
| 0.0 |
0.1 |
GO:0060155 |
platelet dense granule organization(GO:0060155) |
| 0.0 |
0.1 |
GO:0030728 |
ovulation(GO:0030728) |
| 0.0 |
0.8 |
GO:0007257 |
activation of JUN kinase activity(GO:0007257) |
| 0.0 |
0.1 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.0 |
0.1 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
| 0.0 |
0.2 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.0 |
0.7 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.0 |
0.2 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.0 |
0.2 |
GO:0070207 |
protein homotrimerization(GO:0070207) |
| 0.0 |
1.2 |
GO:0070527 |
platelet aggregation(GO:0070527) |
| 0.0 |
0.5 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.0 |
0.2 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.0 |
0.1 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 0.0 |
0.2 |
GO:0018243 |
protein O-linked glycosylation via threonine(GO:0018243) |
| 0.0 |
0.2 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.0 |
0.2 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.0 |
0.1 |
GO:0033273 |
response to vitamin(GO:0033273) |
| 0.0 |
0.1 |
GO:2000726 |
negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) negative regulation of cardiac muscle cell differentiation(GO:2000726) |
| 0.0 |
0.0 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.0 |
0.1 |
GO:0006818 |
hydrogen transport(GO:0006818) |
| 0.0 |
0.0 |
GO:0006560 |
proline metabolic process(GO:0006560) |
| 0.0 |
0.1 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.0 |
0.1 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.0 |
0.1 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.0 |
0.2 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.0 |
0.1 |
GO:0001916 |
positive regulation of T cell mediated cytotoxicity(GO:0001916) |
| 0.0 |
0.1 |
GO:0051957 |
positive regulation of amino acid transport(GO:0051957) |
| 0.0 |
0.1 |
GO:0002467 |
germinal center formation(GO:0002467) |
| 0.0 |
0.0 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.0 |
0.1 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 0.0 |
0.0 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 0.0 |
0.0 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 0.0 |
0.1 |
GO:0030826 |
positive regulation of cGMP metabolic process(GO:0030825) regulation of cGMP biosynthetic process(GO:0030826) |
| 0.0 |
0.0 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.0 |
0.0 |
GO:0060438 |
trachea development(GO:0060438) |
| 0.0 |
0.6 |
GO:0048013 |
ephrin receptor signaling pathway(GO:0048013) |
| 0.0 |
0.1 |
GO:0006283 |
transcription-coupled nucleotide-excision repair(GO:0006283) |
| 0.0 |
0.1 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.0 |
0.1 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 0.0 |
0.0 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
| 0.0 |
0.1 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 0.0 |
0.0 |
GO:0046323 |
glucose import(GO:0046323) |
| 0.0 |
0.3 |
GO:0006919 |
activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) |
| 0.0 |
0.1 |
GO:0019054 |
modulation by virus of host process(GO:0019054) |
| 0.0 |
0.1 |
GO:0070286 |
axonemal dynein complex assembly(GO:0070286) |
| 0.0 |
0.1 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.0 |
0.1 |
GO:0033598 |
mammary gland epithelial cell proliferation(GO:0033598) |
| 0.0 |
0.1 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.0 |
0.0 |
GO:0044803 |
multi-organism membrane organization(GO:0044803) |
| 0.0 |
0.1 |
GO:0007096 |
regulation of exit from mitosis(GO:0007096) |
| 0.0 |
0.1 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.0 |
0.3 |
GO:2000785 |
regulation of autophagosome assembly(GO:2000785) |
| 0.0 |
0.2 |
GO:0070831 |
basement membrane assembly(GO:0070831) |
| 0.0 |
0.1 |
GO:0060088 |
auditory receptor cell stereocilium organization(GO:0060088) |
| 0.0 |
0.1 |
GO:0010574 |
regulation of vascular endothelial growth factor production(GO:0010574) |
| 0.0 |
0.2 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.0 |
0.1 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.0 |
0.1 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.0 |
0.1 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.0 |
0.2 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.0 |
0.1 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.0 |
0.0 |
GO:0043696 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.0 |
0.2 |
GO:0097286 |
iron ion import(GO:0097286) |
| 0.0 |
0.1 |
GO:0006730 |
one-carbon metabolic process(GO:0006730) |
| 0.0 |
0.1 |
GO:0031498 |
chromatin disassembly(GO:0031498) |
| 0.0 |
0.2 |
GO:0061298 |
retina vasculature development in camera-type eye(GO:0061298) |
| 0.0 |
0.3 |
GO:0048821 |
erythrocyte development(GO:0048821) |
| 0.0 |
0.3 |
GO:0006805 |
xenobiotic metabolic process(GO:0006805) |
| 0.0 |
0.1 |
GO:0030539 |
male genitalia development(GO:0030539) |
| 0.0 |
0.1 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.0 |
0.2 |
GO:0051497 |
negative regulation of stress fiber assembly(GO:0051497) |
| 0.0 |
0.0 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.0 |
0.1 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.0 |
0.2 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.0 |
0.0 |
GO:0045351 |
type I interferon biosynthetic process(GO:0045351) |
| 0.0 |
0.1 |
GO:0002176 |
male germ cell proliferation(GO:0002176) regulation of male germ cell proliferation(GO:2000254) |
| 0.0 |
0.0 |
GO:0021895 |
cerebral cortex neuron differentiation(GO:0021895) |
| 0.0 |
0.2 |
GO:0033233 |
regulation of protein sumoylation(GO:0033233) |
| 0.0 |
0.1 |
GO:1903352 |
ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
| 0.0 |
0.0 |
GO:1990414 |
replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.0 |
0.2 |
GO:1990173 |
protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 0.0 |
0.1 |
GO:0097284 |
hepatocyte apoptotic process(GO:0097284) |
| 0.0 |
0.2 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.0 |
0.1 |
GO:0006098 |
pentose-phosphate shunt(GO:0006098) |
| 0.0 |
0.1 |
GO:0001821 |
histamine secretion(GO:0001821) |
| 0.0 |
0.1 |
GO:0048714 |
positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.0 |
0.0 |
GO:0032650 |
regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
| 0.0 |
0.2 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.0 |
0.1 |
GO:0045646 |
regulation of erythrocyte differentiation(GO:0045646) |
| 0.0 |
0.3 |
GO:0034314 |
Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.0 |
0.0 |
GO:0002523 |
leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.0 |
0.1 |
GO:1901739 |
regulation of myoblast fusion(GO:1901739) positive regulation of myoblast fusion(GO:1901741) |
| 0.0 |
0.0 |
GO:0019530 |
taurine metabolic process(GO:0019530) |
| 0.0 |
0.1 |
GO:0045056 |
transcytosis(GO:0045056) |
| 0.0 |
0.1 |
GO:0042832 |
defense response to protozoan(GO:0042832) |
| 0.0 |
0.1 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.0 |
0.0 |
GO:1901678 |
iron coordination entity transport(GO:1901678) |
| 0.0 |
0.0 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.0 |
0.1 |
GO:0033344 |
cholesterol efflux(GO:0033344) |
| 0.0 |
0.2 |
GO:0016064 |
immunoglobulin mediated immune response(GO:0016064) |
| 0.0 |
0.1 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.0 |
0.1 |
GO:0034142 |
toll-like receptor 4 signaling pathway(GO:0034142) |
| 0.0 |
0.0 |
GO:1902396 |
regulation of pinocytosis(GO:0048548) positive regulation of pinocytosis(GO:0048549) protein localization to bicellular tight junction(GO:1902396) |
| 0.0 |
0.1 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.0 |
0.1 |
GO:0045834 |
positive regulation of lipid metabolic process(GO:0045834) |
| 0.0 |
0.0 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
